Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd (BAFNAPH) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 2,004
Jul 11, 2025 Closed
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹83.37
₹-1.19 (-1.41%)
82.61Low
Today’s Performance
85.77High
69.00Low
52 Week’s Performance
94.99High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-1.41%
  • 1 Week-6.55%
  • 1 Month12.07%
  • 3 Months14.99%
  • 6 Months0.64%
  • 1 Year-4.38%
  • 3 Years-9.55%
  • 5 Years30.06%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.22
  • 52-Week Low (₹)69.00
  • 52-Week High (₹)94.99
  • Price-to-Book (X)*2.33
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*47.47
  • Earnings Per Share (₹)1.76
  • Market Cap (₹ Cr.)*197.22
* Values as of last close price

bt_logoCOMPETITORS

BT TV

SEBI Vs Jane Street | Anand Rathi On Retail Losses, F&O Speculation & Market Manipulation Concerns4:43SEBI Vs Jane Street | Anand Rathi On Retail Losses, F&O Speculation & Market Manipulation Concerns
Gautam Adani’s Incredible Journey: From A ₹10,000 Deal To An Empire5:28Gautam Adani’s Incredible Journey: From A ₹10,000 Deal To An Empire
Poco F7 Vs iQOO Neo 10 Vs OnePlus Nord 4: Best Phone Under ₹30,0004:34Poco F7 Vs iQOO Neo 10 Vs OnePlus Nord 4: Best Phone Under ₹30,000
PM E-Drive Launch: E-Truck Buyers To Get Big Incentive, Up To ₹9.6 Lakh3:53PM E-Drive Launch: E-Truck Buyers To Get Big Incentive, Up To ₹9.6 Lakh
Devina Mehra’s Golden Rule: How to Allocate Assets Smartly | Gold, Crypto & Currency Hedge Strategy3:08Devina Mehra’s Golden Rule: How to Allocate Assets Smartly | Gold, Crypto & Currency Hedge Strategy
Why Bharat Electronics Is Helios AMC’s Top Defence Pick | Dinshaw Irani Explains2:37Why Bharat Electronics Is Helios AMC’s Top Defence Pick | Dinshaw Irani Explains
Hindi Three-Language Formula: Marathi Identity Fuels A Political Uprising Against The 2020 NEP In 20255:08Hindi Three-Language Formula: Marathi Identity Fuels A Political Uprising Against The 2020 NEP In 20
Dhirendra Kumar Reveals Framework To Identify Future 100-Bagger Stocks3:56Dhirendra Kumar Reveals Framework To Identify Future 100-Bagger Stocks
Elon Musk’s ‘America Party’: Why He’s Challenging U.S. 'Uniparty' System | History & Hurdles Explained5:06Elon Musk’s ‘America Party’: Why He’s Challenging U.S. 'Uniparty' System | History & Hurdles
What Airtel Teaches Us About 100-Baggers: Dhirendra Kumar’s Investment Playbook4:35What Airtel Teaches Us About 100-Baggers: Dhirendra Kumar’s Investment Playbook
View more

bt_logoFAQ's

What was Bafna Pharmaceuticals Ltd share price previously?
Bafna Pharmaceuticals Ltd share price was down by -1.41% from the previous closing price of ₹84.56.
Who are peers of Bafna Pharmaceuticals Ltd?
The peers of Bafna Pharmaceuticals Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Bafna Pharmaceuticals Ltd?
The promotor/promotors of Bafna Pharmaceuticals Ltd are Shanmugam Hemalatha, Akilapriya Chandrashekar Raju, Ravichandran Chitra, Upendar Mekala Reddy, Vinayak Dinesh Dendukuri, A Mohanachandran, Navin Kumar.
What has been 52-week high of Bafna Pharmaceuticals Ltd stocks?
The highest price of Bafna Pharmaceuticals Ltd stock is ₹94.99 in the last 52-week.
What is the share price of Bafna Pharmaceuticals Ltd (BAFNAPH) today on NSE?
As on Jul 11, 2025 Bafna Pharmaceuticals Ltd (BAFNAPH)’s share price on NSE is Rs 83.37
What is the market cap of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The current market capitalisation of Bafna Pharmaceuticals Ltd (BAFNAPH) is 197.22 crores
What is Bafna Pharmaceuticals Ltd Share symbol?
The symbol of Bafna Pharmaceuticals Ltd is BAFNAPH.
What is the PE ratio of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The current PE ratio of Bafna Pharmaceuticals Ltd (BAFNAPH) is 47.47.
What is the PB ratio of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The current PB ratio of Bafna Pharmaceuticals Ltd (BAFNAPH) is 2.33.
Today’s High & Low share prices of Bafna Pharmaceuticals Ltd (BAFNAPH) on NSE?
Today, the share price of Bafna Pharmaceuticals Ltd (BAFNAPH) on NSE touched a high of Rs 85.77 and a low of Rs 82.61
What price did Bafna Pharmaceuticals Ltd (BAFNAPH) shares open on the NSE today?
On NSE, the share price of Bafna Pharmaceuticals Ltd (BAFNAPH) opened at Rs 85.03
What is the 52-week high of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The 52-week high price of Bafna Pharmaceuticals Ltd (BAFNAPH) is Rs 94.99
What is the 52-week low of Bafna Pharmaceuticals Ltd (BAFNAPH)?
The 52-week low price of Bafna Pharmaceuticals Ltd (BAFNAPH) is Rs 69.00

bt_logoAbout Bafna Pharma.

Bafna Pharmaceuticals Ltd, incorporated in the year 1995, has its registered office in Bafna Towers New No 68, Old No 299 Thambu Chetty St, Chennai, Tamil Nadu, 600001, 91-44-25267517/25270992/4267755, 91-44-25231264/42677599. The main industry in which Bafna Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Bafna Pharmaceuticals Ltd is/are Brahmayya & Co. In the main management, is chairman and A Mohanachandran is the company secretary for Bafna Pharmaceuticals Ltd.

  • SH
    Shanmugam HemalathaWhole Time Director
  • ACR
    Akilapriya Chandrashekar RajuNon-Exec & Non-Independent Dir
  • RC
    Ravichandran ChitraNon-Exec. & Independent Dir.
  • UMR
    Upendar Mekala ReddyNon Executive Director
  • VDD
    Vinayak Dinesh DendukuriWhole-time Director
  • AM
    A MohanachandranCompany Sec. & Compli. Officer
  • NK
    Navin KumarAdditional Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.